VEGFA and Barrett esophagus: At the same time, it is correlated with worse outcomes, suggesting the potential use of anti-VEGF agents for treating EAC patients who present it, while the expression of VEGF-A and -C is elevated throughout the transition from BE to EAC, indicating their potential association with metastasis and advanced disease stages [41,42].